Fabtech Technologies Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Attractively valued vs sector (P/E 13x vs industry 50.2x)
- Low debt relative to equity (D/E 0.2x)
- Near 52-week low — potential value zone (₹116)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Corporate Events
To consider dividend for the Financial Year ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026
Latest News
All newsFabtech Technologies acquires undisclosed business for growth
*Fabtech Technologies acquires undisclosed business for growth.* The company aims to expand its operational footprint and diversify revenue streams. The acquisition value and target remain undisclosed. Integration is expected to be completed within **6–8 months**. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #Acquisition
Fabtech Technologies announces change in management
*Fabtech Technologies announces change in management* — The company has disclosed a leadership transition following a corporate filing with the NSE. No further details on outgoing or incoming executives were provided. Such changes may influence strategic direction and investor sentiment. \n\n 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #ManagementChange
Fabtech Technologies announces board meeting outcomes.
*Fabtech Technologies announces board meeting outcomes.* The company disclosed outcomes from its June 25, 2026, board meeting via a filing. No major strategic decisions or financial announcements were detailed. The update is routine in nature with no immediate market-moving implications. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #CorporateUpdate
Fabtech Technologies announces board meeting outcomes.
*Fabtech Technologies announces outcomes from its recent board meeting.* No major financial or strategic decisions disclosed. Event reflects routine corporate governance. Details remain limited to compliance filing. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #BoardMeeting
Fabtech enters CIS with new turnkey project.
*Fabtech enters CIS with new turnkey project.* The company has secured a design-and-build contract in a Commonwealth of Independent States (CIS) country, marking its international expansion. This new order diversifies its revenue base and strengthens project portfolio. Execution success could lead to follow-on orders. 📊 *STOCKS:* $FABTECH | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #OrderWin
Fabtech subsidiary completes 14,000 sqm facility for Himalaya in UAE
*Fabtech subsidiary completes 14,000 sqm facility for Himalaya in UAE* — FTS Cleanrooms Systems LLC, a step-down subsidiary of Fabtech Technologies, has delivered a **14,000 sqm** turnkey facility for Himalaya Wellness Company in the UAE within a year. The project highlights Fabtech’s growing international footprint in cleanroom infrastructure. Execution efficiency underscores its project management strength in specialized construction. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* Engineering | #MEDIUMIMPACT #OrderWin
Fabtech to host analyst and investor call for Q2FY27
*Fabtech to host analyst and investor call for Q2FY27* to discuss business updates and financial performance. The event is scheduled for an upcoming date with registration open online. Investors can access insights on operational progress and future outlook. 📊 *STOCKS:* $FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Concall
Fabtech Technologies hosts investor meet with no major announcements.
*Fabtech Technologies hosts investor meet with no major announcements.* The company updated analysts and institutional investors on business performance and strategy. No new financial guidance or operational updates were disclosed. The event was part of routine investor engagement. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #InvestorMeet
Fabtech Technologies holds annual general meeting
*Fabtech Technologies holds annual general meeting*. Fabtech Technologies Limited conducted its Annual General Meeting on August 24, 2026, and submitted the scrutinizer's report to the exchange. Voting results from the meeting were also disclosed. The filing is a routine corporate update with no immediate financial or strategic implications. 📊 *STOCKS:* $FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #AGM
Fabtech Technologies to hold 8th AGM.
*Fabtech Technologies to hold 8th AGM.* The company has published notice for its annual general meeting as per regulatory requirements. No financial updates or material announcements were disclosed. The event is a routine corporate exercise. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #AGM
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹159 Cr 152.4% | ₹63 Cr 47.9% | ₹121 Cr 77.9% | ₹68 Cr 49.6% | ₹135 Cr 29.8% | ₹104 Cr 76.3% | ₹59 Cr |
| Op. Profit | ₹22 Cr 283.3% | ₹-12 Cr 140.0% | ₹30 Cr 600.0% | ₹-6 Cr 133.3% | ₹18 Cr 21.7% | ₹23 Cr 360.0% | ₹5 Cr |
| OPM | 14.0% 177.8% | -18.0% 172.0% | 25.0% 377.8% | -9.0% 164.3% | 14.0% 36.4% | 22.0% 175.0% | 8.0% |
| Net Profit | ₹22 Cr 466.7% | ₹-6 Cr 121.4% | ₹28 Cr 566.7% | ₹-6 Cr 140.0% | ₹15 Cr 25.0% | ₹20 Cr 300.0% | ₹5 Cr |
| EPS (₹) | 4.96 487.5% | -1.28 114.7% | 8.68 559.3% | -1.89 140.6% | 4.66 26.3% | 6.32 300.0% | 1.58 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹411 Cr 25.7% | ₹327 Cr 44.7% | ₹226 Cr 16.5% | ₹194 Cr 24.5% | ₹257 Cr 112.4% | ₹121 Cr 9.0% | ₹133 Cr |
| Expenses | ₹376 Cr 30.6% | ₹288 Cr 50.8% | ₹191 Cr 13.0% | ₹169 Cr 24.9% | ₹225 Cr 104.5% | ₹110 Cr 7.6% | ₹119 Cr |
| Op. Profit | ₹35 Cr 10.3% | ₹39 Cr 11.4% | ₹35 Cr 40.0% | ₹25 Cr 21.9% | ₹32 Cr 190.9% | ₹11 Cr 21.4% | ₹14 Cr |
| OPM | 9.0% 25.0% | 12.0% 20.0% | 15.0% 15.4% | 13.0% 8.3% | 12.0% 33.3% | 9.0% 18.2% | 11.0% |
| Other Income | ₹23 Cr 14.8% | ₹27 Cr 350.0% | ₹6 Cr 40.0% | ₹10 Cr 150.0% | ₹4 Cr 100.0% | ₹2 Cr 60.0% | ₹5 Cr |
| Interest | ₹4 Cr 33.3% | ₹3 Cr 0.0% | ₹3 Cr 40.0% | ₹5 Cr 66.7% | ₹3 Cr 50.0% | ₹2 Cr 0.0% | ₹2 Cr |
| Depreciation | ₹5 Cr 66.7% | ₹3 Cr 50.0% | ₹2 Cr 0.0% | ₹2 Cr 0.0% | ₹2 Cr | ₹0 Cr | ₹0 Cr |
| PBT | ₹48 Cr 20.0% | ₹60 Cr 66.7% | ₹36 Cr 28.6% | ₹28 Cr 9.7% | ₹31 Cr 181.8% | ₹11 Cr 31.3% | ₹16 Cr |
| Tax % | 21.0% 8.7% | 23.0% 4.2% | 24.0% 9.1% | 22.0% 12.0% | 25.0% 13.8% | 29.0% 7.4% | 27.0% |
| Net Profit | ₹38 Cr 17.4% | ₹46 Cr 70.4% | ₹27 Cr 22.7% | ₹22 Cr 4.3% | ₹23 Cr 187.5% | ₹8 Cr 33.3% | ₹12 Cr |
| EPS (₹) | 8.63 39.8% | 14.34 84.5% | 92.44 18.5% | 78 7.5% | 84.28 99.0% | 8,040 35.1% | 12,390 |
| Div Payout | 7.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||
| Equity Capital | ₹44 Cr 37.5% | ₹32 Cr 0.0% | ₹32 Cr 966.7% | ₹3 Cr 0.0% | ₹3 Cr 0.0% | ₹3 Cr 29900.0% | ₹0.01 Cr 0.0% | ₹0.01 Cr |
| Reserves | ₹375 Cr 131.5% | ₹162 Cr 14.9% | ₹141 Cr 9.3% | ₹129 Cr 50.0% | ₹86 Cr 32.3% | ₹65 Cr 41.3% | ₹46 Cr 21.1% | ₹38 Cr |
| Borrowings | ₹70 Cr 66.7% | ₹42 Cr 50.0% | ₹84 Cr 546.2% | ₹13 Cr 62.9% | ₹35 Cr 66.7% | ₹21 Cr 133.3% | ₹9 Cr 800.0% | ₹1 Cr |
| Other Liabilities | ₹164 Cr 9.4% | ₹181 Cr 6.5% | ₹170 Cr 36.0% | ₹125 Cr 40.4% | ₹89 Cr 7.2% | ₹83 Cr 18.6% | ₹70 Cr 16.7% | ₹84 Cr |
| Total Liabilities | ₹654 Cr 56.5% | ₹418 Cr 2.1% | ₹427 Cr 58.7% | ₹269 Cr 25.7% | ₹214 Cr 24.4% | ₹172 Cr 36.5% | ₹126 Cr 2.4% | ₹123 Cr |
Assets | ||||||||
| Fixed Assets | ₹78 Cr 1.3% | ₹79 Cr 16.0% | ₹94 Cr 327.3% | ₹22 Cr 450.0% | ₹4 Cr 20.0% | ₹5 Cr 150.0% | ₹2 Cr 0.0% | ₹2 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹26 Cr 4.0% | ₹25 Cr 66.7% | ₹15 Cr 28.6% | ₹21 Cr 5.0% | ₹20 Cr 17.6% | ₹17 Cr 142.9% | ₹7 Cr 41.7% | ₹12 Cr |
| Other Assets | ₹550 Cr 75.7% | ₹313 Cr 1.6% | ₹318 Cr 40.7% | ₹226 Cr 18.9% | ₹190 Cr 26.7% | ₹150 Cr 29.3% | ₹116 Cr 6.4% | ₹109 Cr |
| Total Assets | ₹654 Cr 56.5% | ₹418 Cr 2.1% | ₹427 Cr 58.7% | ₹269 Cr 25.7% | ₹214 Cr 24.4% | ₹172 Cr 36.5% | ₹126 Cr 2.4% | ₹123 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹0 Cr 100.0% | ₹-36 Cr 160.0% | ₹60 Cr 528.6% | ₹-14 Cr 366.7% | ₹-3 Cr 66.7% | ₹-9 Cr 114.1% | ₹64 Cr |
| Investing CF | ₹-112 Cr 460.0% | ₹-20 Cr 33.3% | ₹-30 Cr 1600.0% | ₹2 Cr 122.2% | ₹-9 Cr 325.0% | ₹4 Cr 114.3% | ₹-28 Cr |
| Financing CF | ₹190 Cr 427.8% | ₹36 Cr 400.0% | ₹-12 Cr 200.0% | ₹12 Cr 50.0% | ₹8 Cr 33.3% | ₹6 Cr 126.1% | ₹-23 Cr |
| Net Cash Flow | ₹78 Cr 490.0% | ₹-20 Cr 211.1% | ₹18 Cr | ₹0 Cr 100.0% | ₹-4 Cr 500.0% | ₹1 Cr 92.3% | ₹13 Cr |
| Free Cash Flow | ₹5 Cr 108.2% | ₹-61 Cr 203.4% | ₹59 Cr 521.4% | ₹-14 Cr 250.0% | ₹-4 Cr 55.6% | ₹-9 Cr 114.1% | ₹64 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 182d 8.3% | 168d 7.7% | 156d 16.6% | 187d 55.8% | 120d 11.1% | 135d 22.7% | 110d |
| Inventory Days | 32d 73.1% | 119d 35.2% | 88d 27.5% | 69d 305.9% | 17d 56.4% | 39d 77.3% | 22d |
| Days Payable | 159d 19.7% | 198d 1.5% | 195d 9.3% | 215d 58.1% | 136d 9.3% | 150d 82.9% | 82d |
| Cash Conv. Cycle | 55d 38.2% | 89d 81.6% | 49d 19.5% | 41d 4000.0% | 1d 96.0% | 25d 51.0% | 51d |
| Working Capital Days | 90d 69.8% | 53d 15.9% | 63d 3.1% | 65d 116.7% | 30d 100.0% | 15d 178.9% | -19d |
| ROCE | 14.0% 36.4% | 22.0% 21.4% | 28.0% 9.7% | 31.0% 35.4% | 48.0% 84.6% | 26.0% | — |
Source: Screener.in · Lower days = better efficiency
About Fabtech Technologies Limited
Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.[1]
HealthcareHealthcare Services